2.Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B in China
Min-De ZENG ; Yi-Min MAO ; Guangbi YAO ;
Chinese Journal of Infectious Diseases 2001;0(06):-
Objective To evaluate the efficacy and safety of Adefovir dipivoxil in the 52-week treatment of chronic hepatitis B in China.Methods We randomly assigned 480 patients with chronic hepatitis B who were positive for hepatitis B e antigen(HBeAg)in China.During the first 12-week period,480 patients were randomly to receive either 10 mg of adefovir dipivoxil(ADV)or placebo once daily in a 2:1 ratio and in the second period,all patients were accepted ADV for 18 weeks.In the last 12-week stage,all patients treated by ADV were randomly to receive either 10 mg of ADV or placebo in a 2:1 ratio and patients treated by placebo were accepted ADV.The primary end point was serum HBV DNA change during the treatment.The secondary endpoints were ALT normalization rate,HBeAg loss rate and HBeAg seroconversion rate.Results At week 12,median serum hepatitis B virus(HBV)DNA levels of group AAA(ADV-ADV-ADV)and group AAP(ADV-ADV-Placebo) were reduced 3.4 and 3.3 log copies per milliliter,significantly greater than group PAA(Placebo- ADV-ADV)of 0.1 log copies/ml reduction(P
4.Pnehyclidine hydrochloride as anticholinergic drug to treat severe acute organophosphorus pesticide poisoning
Min-Jie MAO ; Kun FANG ; Yi-Hua ZHENG ;
Chinese Journal of Primary Medicine and Pharmacy 2006;0(12):-
Objective To determine the effect of pnehyclidine hydrochloride as anticholinergic drug during the treatment of severe acute organophosphorus pesticide poisoning(SAOPP)and evaluate the safety.Methods 78 SAOPP patients was divided into control group(n=37)and test group(n=41).Atropine was as anticholinergic drug in control group and was replaced by pnehyclidine hydrochloride in test group.The persistence time of mus- carinic action,drug adverse reaction,severe complication,healing rate and therapeutic time of detoxification after these drugs being administered were observed in the two groups.Results The persistence time of muscarinic action was shorter in rest group than in control group(P
5.Pharmacokinetics of single dose intravenous infusion of magnesium isoglycyrrhizinate in patients with chronic hepatic impairment
xiao-dong, YAO ; jin-fang, SHEN ; yi-min, MAO ; min-de, ZENG
Journal of Shanghai Jiaotong University(Medical Science) 2006;0(02):-
0.05). Conclusion The elimination half-life of magnesium isoglycyrrhizinate in patients with chronic hepatic impairment is 27 h,and the regiment of 100 mg once a day is recommended.
7.Recognition of experimental animal model with kidney disease.
Yi-gang WAN ; Yan-ru HUANG ; Wei SUN ; Zhi-min MAO ; Xi-miao SHI ; Jian YAO
China Journal of Chinese Materia Medica 2014;39(21):4075-4081
Animal models with kidney disease are generally divided into two types. One belongs to the models which imitate human kidney disease by the artificial operations, such as anti-glomerular basement membrane antibody nephritis, Heymann nephritis, anti-Thyl. 1 antibody nephritis, BSA nephritis and puromycin nephropathy. The other one pertains to the models which make themselves kidney disease, and appear the pathological characteristics naturally as like as human, such as HIGA mice with IgA nephropathy and NZB/WF1 and MRL/1pr mice with lupus nephritis. In addition,the transgenic animal models with kidney disease can also be established by the modern molecular biologic techniques including gene knockout and siRNA transfection. As for the studies related with kidney disease in pharmacodynamics and pharmacology of Chinese herbal medicine (CHM), it is important to understand deeply the features of each animal model with kidney disease, and select accurately the proper models according to the different experimental objectives, and then, build the special models provided with the combination of disease with syndrome in traditional Chinese medicine (TCM). Therefore,it is the developmental direction for the further study to establish animal models with kidney disease, which should possess the characteristics of syndrome in TCM.
Animals
;
Diabetic Nephropathies
;
etiology
;
Disease Models, Animal
;
Humans
;
Kidney Diseases
;
etiology
;
Medicine, Chinese Traditional
;
Mice
;
Streptozocin
8.Progress in preparation of small monoclonal antibodies of knock out technique.
Jing LIU ; Xin-min MAO ; Lin-lin LI ; Xin-xia LI ; Ye WANG ; Yi LAN
China Journal of Chinese Materia Medica 2015;40(19):3737-3741
With the application of monoclonal antibody technology more and more widely, its production technology is becoming more and more perfect. Small molecule monoclonal antibody technology is becoming a hot research topic for people. The application of traditional Chinese medicine small molecule monoclonal antibody technology has been more and more widely, the technology for effective Chinese medicine component knockout provide strong technical support. The preparation of monoclonal antibodies and small molecule knockout technology are reviewed in this paper. The preparation of several steps, such as: in the process of preparation of antigen, hapten carrier coupling, coupling ratio determination and identification of artificial antigen and establishment of animal immunization and hybridoma cell lines of monoclonal antibody, the large-scale preparation; small molecule monoclonal antibody on Immune in affinity chromatography column method is discussed in detail. The author believes that this technology will make the traditional Chinese medicine research on a higher level, and improve the level of internationalization of Chinese medicine research.
Animals
;
Antibodies, Monoclonal
;
chemistry
;
genetics
;
immunology
;
Humans
;
Hybridomas
;
metabolism
;
Immunologic Techniques
;
methods
;
trends
9.Efficacy of neoadjuvant chemotherapy with antracyclines plus paclitaxel or docetaxel regimen in stageⅢbreast cancer patients
Zi-Yi YIN ; Pi-Lin WANG ; Tie ZHANG ; Mao-Min SONG ;
China Oncology 2000;0(06):-
Background and purpose:Antracycline combined with paclitaxel is more widely applied in breast cancer as neoadjuvant chemotherapy.There are differences in applications of different paclita~els.In this research,the efficacy and toxicity of neoadjuvant chemotherapy with ET,ED regimen were compared for the patients with stageⅢbreast cancer.Methods:64 cases of stageⅢbreast cancer patients were divided in two groups.Before surgery,one group had received ET(EPI ivgtt 60 mg/m~2 d_1?21,PTX ivgtt 175 mg/m~2 d_2?21),the other group had received ED(EPI ivgtt 60 mg/m~2 d_2?21,DOC ivgtt 75 mg/m~2 d_2?21)neoadjuvant chemotherapy for three weeks. Curative effect and side effects were evaluated after 2-4 cycles.Results:Total effective rate was 87.5%.Effective rate in ED group was 92.9%,and effective rate in ET group was 83.5%.There was no significant difference(P=0.253).In pCR cases,8 cases in ED group achieved pathologically complete response compared to 3 cases in ET group(P=0.033). The number of patients in ED group(24 cases)hadⅣ-Ⅴgrade pathology evaluation after chemotherapy,it was higher than that in ET patients(21 cases).There was a significant difference(P=0.017).In both groups side effects including hair loss,nausea and vomiting,liver dysfunction were similar.Incidence rate of peripheral neurotoxicity in ET group was higher than that in ED group(P=0.002).Incidence rates of leukopenia,skin rash and phlebitis in ED group were higher than that in ET group.There was a significant difference between two groups in the leukopenia(P=0.034). Conclusions:For the patients with stageⅢbreast cancer patients,both two regimens could achieve better curative effect.ET and ED regimen have similar effect.But in ED regimen,the number ofpCR cases was obviously higher than in ET group.In both groups side effects were similar.There were significant differences in terms of leukopenia and peripheral neurotoxicity,but the side effects could be tolerated.
10.Adefovir dipivoxil-A new drug for hepatitis B.
Chinese Journal of Hepatology 2004;12(1):61-63